David Mountcastle - Oct 5, 2022 Form 4/A - Amendment Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/Thomas Bartrum, , as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Oct 5, 2022
Transactions value $
-$140,331
Form type
4/A - Amendment
Date filed
12/20/2022, 03:08 PM
Date Of Original Report
Oct 6, 2022
Previous filing
Sep 8, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $8.33K +4.17K +2.62% $2.00* 163K Oct 5, 2022 Direct F1
transaction PRVA Common Stock, $0.01 par value per share Sale -$131K -3.67K -2.24% $35.63 160K Oct 5, 2022 Direct F1, F2, F3
transaction PRVA Common Stock, $0.01 par value per share Sale -$18K -500 -0.31% $36.02 159K Oct 5, 2022 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 6, 2022, the reporting person filed a Form 4 (the "Original Form 4") which incorrectly reported that, following his exercise of an option and sales of the underlying common stock, he directly held 91,371 shares of the issuer's common stock. This amendment on Form 4/A is being filed to correct the number of shares as reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction" in each row of Table I of the Original Form 4. As a result of the error, the direct holdings of the reporting person was understated by 67,824 shares in a subsequent Form 4 filed by the reporting person. As of the date of this amendment, the reporting person directly beneficially owns 215,062 shares of common stock
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.00 to $36.04 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.